HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Rancho Mirage [beta 143(H21)His----Asp]; a variant in the 2,3-DPG binding site showing normal oxygen affinity at physiological pH.

Abstract
Hb Rancho Mirage was detected in a 17-year-old male in association with a mild anemia. Hemoglobin electrophoresis revealed the variant had a mobility between Hbs A and J on cellulose acetate (pH 8.6) and a mobility like Hb F on citrate agar (pH 6.4). A substitution of His----Asp was found at position 143 in the beta chain, a residue that contributes to the anionic 2,3-DPG binding site in Hb. This variant exhibited normal oxygen affinity at physiologic pH and reduced affinity at alkaline pH. This suggested a subtle shift in the allosteric equilibrium due most likely to the introduction of a negative charge that stabilized the 2,3-DPG pocket. Both homotrophic (heme-heme) and heterotropic (2,3-DPG and protons) effects were reduced; this might be a consequence of an alteration in the carboxyl terminal region of the beta-subunits. Although a His----Asp substitution would be considered to cause reasonable disruption of the 2,3-DPG and C-terminal conformation of the beta- subunits, the properties of Hb Rancho Mirage suggest that, in fact, there appear to be no major perturbation of the critical C-terminal residues.
AuthorsW F Moo-Penn, T K Hine, M H Johnson, D L Jue, S Holland, S George, A M Pierce, L A Michalski, M J McDonald
JournalHemoglobin (Hemoglobin) Vol. 16 Issue 1-2 Pg. 35-44 ( 1992) ISSN: 0363-0269 [Print] England
PMID1634360 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Diphosphoglyceric Acids
  • Hemoglobins, Abnormal
  • 2,3-Diphosphoglycerate
  • hemoglobin Rancho Mirage
  • Oxygen
Topics
  • 2,3-Diphosphoglycerate
  • Adolescent
  • Binding Sites
  • Diphosphoglyceric Acids (chemistry)
  • Hemoglobins, Abnormal (metabolism)
  • Humans
  • Hydrogen-Ion Concentration
  • Kinetics
  • Male
  • Oxygen (metabolism)
  • Peptide Mapping

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: